Overview
The goal of this series is to update GW providers, faculty, and researchers about the latest advances in vaccines and vaccine research, to both provide opportunities and ideas for future research at GW but also to increase competence in advising patients on the current guidance for different vaccines.
 
Learning Objectives
To describe the most up-to-date research and available products related to vaccines including those for RSV, Dengue, enteric infections, and malaria.
 
Target Audience

This activity is intended to meet the educational needs of the healthcare team including but not limited to:

  • Physicians
  • Residents
  • Medical Students
  • Physician assistants
  • Nurses
  • Other Healthcare Professionals
Activity Director
David Diemert, MD
Professor of Medicine
Professor of Microbiology, Immunology, and Tropical Medicine 
Professor of Epidemiology
The George Washington University
 
Faculty
Name
Title
Institution
 
Disclosure of Relevant Financial Relationships
In accordance with the Standards for Integrity and Independence, GW requires all planners, faculty, and others in a position to control the educational content of an accredited CE activity to disclose the absence or existence of all financial relationships (of any dollar amount) with any ineligible companies within the past 24 months.
An ineligible company is any entity whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
GW reviews all disclosure statements to determine which financial relationships are relevant to the educational content of the CE activity. An individual is considered to have a relevant financial relationship if the educational content they can control is related to the business lines or products of the ineligible company.
 
Disclosure Statement(s)
Absence of Relevant Financial Relationships
None of the planners, faculty, staff, or others in a position to control the content of this educational activity have relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
Session date: 
05/07/2025 - 11:09am EDT
Add to calendar: 

Please login or register to take this course.